174 related articles for article (PubMed ID: 31081077)
21. MiRNA-206 suppresses the metastasis of osteosarcoma via targeting Notch3.
Cai WT; Guan P; Lin MX; Fu B; Wu B; Wu J
J Biol Regul Homeost Agents; 2020; 34(3):775-783. PubMed ID: 32627519
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
Qu C; Dai C; Guo Y; Qin R; Liu J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
[TBL] [Abstract][Full Text] [Related]
23. LINC00339 accelerates invasion and migration of colorectal cancer via mediating miRNA-30a-5p.
Zhou P; Wu J; Zheng Z; Liao C; Sun X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):226-231. PubMed ID: 38279428
[TBL] [Abstract][Full Text] [Related]
24. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
Zhao YL; Huang YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
[TBL] [Abstract][Full Text] [Related]
25. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
26. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
[TBL] [Abstract][Full Text] [Related]
27. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
[TBL] [Abstract][Full Text] [Related]
28. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
29. LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9.
Tong WH; Mu JF; Zhang SP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6639-6646. PubMed ID: 32633353
[TBL] [Abstract][Full Text] [Related]
30. LINC00922 Accelerates the Proliferation, Migration and Invasion of Lung Cancer Via the miRNA-204/CXCR4 Axis.
Liang T; Wang B; Li J; Liu Y
Med Sci Monit; 2019 Jul; 25():5075-5086. PubMed ID: 31287095
[TBL] [Abstract][Full Text] [Related]
31. LncRNA AK024094 aggravates the progression of breast cancer through regulating miRNA-181a.
Zheng TZ; Li YT; Li WJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1913-1921. PubMed ID: 32141560
[TBL] [Abstract][Full Text] [Related]
32. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
33. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
35. LINC01342 promotes the progression of ovarian cancer by absorbing microRNA-30c-2-3p to upregulate HIF3A.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
J Cell Physiol; 2020 Apr; 235(4):3939-3949. PubMed ID: 31595977
[TBL] [Abstract][Full Text] [Related]
36. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
37. PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.
Xuan ZH; Wang HP; Zhang XN; Chen ZX; Zhang HY; Gu MM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5259-5266. PubMed ID: 32495859
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
39. MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.
Niu XY; Zhang ZQ; Ma PL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6983-6990. PubMed ID: 31486498
[TBL] [Abstract][Full Text] [Related]
40. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]